What is a common presentation of Intralobar Pulmonary Sequestration (ILPS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Intralobar Pulmonary Sequestration Presentation

Intralobar pulmonary sequestration most commonly presents with recurrent pneumonia, which corresponds to option (c) in the multiple choice question.

Clinical Presentation of Intralobar Pulmonary Sequestration

Intralobar pulmonary sequestration (ILPS) is characterized by the following clinical features:

  • Recurrent pneumonia (most common presentation)
  • History of chronic cough
  • Intermittent fevers
  • Symptoms that may persist despite multiple courses of antibiotics

The evidence strongly supports recurrent pneumonia as the predominant presentation, with 90% of patients in one study having a history of recurrent pulmonary infections 1. This pattern of recurrent infections in the same lower lobe should raise suspicion for an intralobar sequestration.

Pathophysiology and Location

Intralobar pulmonary sequestration is a congenital malformation with these key characteristics:

  • Non-functioning embryonic lung tissue
  • Abnormal systemic arterial supply (typically from the thoracic or abdominal aorta)
  • No normal connection to the tracheobronchial tree
  • Most commonly located in the lower lobes (60-90%)
  • Left lower lobe is more frequently affected than right (70% vs 30%)

The abnormal connection and drainage predispose the sequestered lung tissue to infection, explaining the pattern of recurrent pneumonia 2, 3.

Diagnostic Considerations

When evaluating a patient with suspected ILPS:

  • Chest radiographs are abnormal but often non-specific
  • CT with IV contrast or CTA chest is the preferred imaging modality 4
  • CT can identify the sequestered lung tissue and its abnormal vascular supply
  • Thoracic arteriography can visualize the systemic arterial supply and help prevent surgical complications

The diagnosis is often delayed (mean delay of 1.5 years in one study) due to symptoms being attributed to common respiratory conditions 1. In patients over 50, the diagnosis may be even more challenging as ILPS is rare in this age group 3.

Other Potential Presentations

While recurrent pneumonia is the most common presentation, other symptoms may include:

  • Hemoptysis (can be severe and potentially fatal in some cases) 5
  • Chronic cough
  • Chest pain 3

Some patients (approximately 10%) may be asymptomatic with the condition discovered incidentally on imaging 1.

Management

Definitive treatment involves surgical resection:

  • Lobectomy is the most common procedure
  • Video-assisted thoracoscopic surgery (VATS) is a minimally invasive option
  • Identification and careful management of the aberrant systemic artery is crucial to prevent catastrophic bleeding

Early diagnosis and surgical intervention are important to prevent complications from recurrent infections and potential hemoptysis 1, 2.

Key Takeaway

When evaluating patients with recurrent lower lobe pneumonia, particularly in the same location, maintain a high index of suspicion for intralobar pulmonary sequestration. Early diagnostic imaging with contrast-enhanced CT or CTA is warranted to identify this uncommon but clinically significant condition.

References

Research

Intralobar sequestration. A missed diagnosis.

The Annals of thoracic surgery, 1989

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intralobar sequestration of lung.

Lung India : official organ of Indian Chest Society, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.